Dr. Elyse Watkins
Currently,the prescribed recommended dose of rifampicin is 10mg/kg or a 600mg daily. This dose was developed as the minimum effective dose over 50 years ago. The obstacle to effective clinical control in outpatient tuberculosis (TB) therapy is compliance due to a lengthy one year of therapy combined withrifampicin at 600mg daily dosing.It is known that treatment completion remains a significant challenge in the United States (US) with only 30% to 64% of patients completing treatment causing more resistance and more transmission of the disease to a vulnerable unknowing population. Eradication of TB weighs heavily on upgrading of the medication dosing regimens thus providing a quicker sputum culture conversion, resulting in a decrease transmission of the disease.Shortening TB treatment to six months and correspondingly increasing the dose of rifampicin to 1200mg daily dosing was associated with better results at achieving a quicker sputum culture conversion.
Screnci, Giuseppe A.
"In patients with Pulmonary Tuberculosis will higher doses of Rifampicin/Rifampin coupled with a shorter treatment regimen as oppose to standard dosing and therapy result in better treatment response?,"
Lynchburg Journal of Medical Science: Vol. 1
, Article 76.
Available at: https://digitalshowcase.lynchburg.edu/dmscjournal/vol1/iss3/76
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.